The development of the new variant of the Coronavirus (COVID-19) is always a hot topic in the media as scientists look at new variants. As we have now had the virus change our lives nearly 7 years ago we are beginning to see a new variant, PJ.2.1, being studied due to the genetic mutations and increase in cases globally. The first case of this new variant was recorded in Canada in May 2026. This new variant has been identified in many countries since. We need to understand what we know about this new variant to keep ourselves up-to-date but to avoid creating panic.
Understanding the new COVID-19 variant (PJ.2.1)
This new variant is a saltation variant meaning it has developed with many genetic mutations. It is a new variant of SARS-CoV-2 which causes the disease known as COVID-19.
It was identified from MC.10.1.7 variant which is part of the JN.1 lineage. This new variant was first recorded in Ontario, Canada on the 2nd May 2026. Since this date it has been identified in other provinces in Canada and globally. An important aspect to note about this new variant is the high level of mutations on the spike protein. This protein is important to help the virus attach to cells in the human body.
Key Point: Genetic mutations can affect how easy the virus can enter cells, transmit and how immune systems can react. However, we cannot determine this variant causes more severe illness.
International spread of PJ.2.1
Since this new variant was identified in Canada it has been found in many countries. The United States have identified cases in New York, California, Arizona, Florida and many more states.
Other countries who have identified cases are; Singapore, Australia, New Zealand, Israel, France and Spain. There have also been evidence of local transmission in many areas of Spain.
A report from Public Health Ontario (2nd November 2026) shows how prevalent this variant is becoming. Between the 20th September and 17th October, 25.2% of the SARS-CoV-2 samples sequenced were PJ.2.1. This compares to 16.9% over the previous 4 weeks. This means this new variant is becoming more prevalent in some groups. However, there can be large differences between countries.
Symptoms of the PJ.2.1 variant
There are currently no specific symptoms identified for this new variant. The symptoms will be similar to other cases of COVID-19.
Potential symptoms are:
Fever: High temperature and feeling unwell.
Cough: A dry or productive cough that lasts for a few days.
Sore throat: Feeling uncomfortable, painful or irritated when swallowing.
Runny/Nasal congestion: Nasal congestion similar to what you get during seasons.
Headache and muscle aches: Feeling uncomfortable in muscles, headaches and overall feeling weak.
Tiredness: Feeling unusually tired and lacking energy.
Gastrointestinal issues: Some people may feel nauseous, vomit or suffer with diarrhoea.
Other symptoms may include difficulty breathing and changes in taste/smell.
An important thing to remember is that the symptoms for COVID-19 can often be similar to flu and colds. Therefore we cannot rely on symptoms to identify if someone has the infection. Getting the correct tests can help show you if you have the virus. Is the PJ.2.1 variant more dangerous?
One of the most important questions is how severe this new variant can be.
Lab studies have shown the spike protein has changes in how it interacts with ACE2 receptors (found on human cells). Some lab studies have shown the virus can enter cells more efficiently. This can help the virus create infections.
However, this does not mean it is more dangerous.
There is no evidence to show this variant causes more hospitalisations, deaths and severe illness compared to previous variants.
Just because it can be transmitted more easily does not mean it causes more severe illness. These are two different factors and will need to be researched.
Older adults, those with weakened immune systems and people with Diabetes, heart conditions or chronic lung conditions should be extra cautious.
Are we protected by existing vaccines?
As new variants of the SARS-CoV-2 virus are identified it is important to know how effective our vaccines are. The study showed how variants adapted vaccines produce antibodies to interact with the PJ.2.1 variant. Lab studies have shown that those who have received a booster dose adapted to the LP.8.1 variant still had neutralising antibodies.
This is positive news as it shows the vaccines we already have can still provide some protection.
However, this does not show how effective the vaccines will be in preventing infection.
Vaccination is an important factor in protecting yourself. It can help reduce the chances of severe illness, hospitalisation and death. Those at higher risk should speak to a qualified healthcare professional to identify what vaccinations they need and what boosters they should receive. Important precautions to reduce your risk of infection
Whilst this variant should be monitored, it is important to take the usual precautions to protect against respiratory infections.
Wear a face mask that fits well in busy and poorly ventilated areas.
Ensure you have good ventilation.
Wash your hands regularly and practice good respiratory hygiene.
Avoid close contact with others if you have any respiratory symptoms.
If you begin to experience symptoms consider getting tested for COVID-19, especially if you live with vulnerable people.
Contact a medical professional if your symptoms worsen.
If you are struggling to breathe, have ongoing chest pain, become confused or unable to stay awake seek medical attention immediately.
What should we know about the PJ.2.1 variant in India?
This new variant highlights how important it is to continue effective genomic monitoring. Monitoring new variants of the SARS-CoV-2 virus can help identify new transmission trends. As of the 13th November 2026 there is no evidence to show this variant is widely spreading in India. However, as it has been identified internationally it should be monitored.
The World Health Organisation provide information on variants they are monitoring. This new variant was not listed on their update in July 2026 (variants of interest/concern).
Conclusion
The new variant of COVID-19 (PJ.2.1) shows us that the virus is still evolving. The increase in cases globally and unique genetic features should be looked into by scientists. However, there is not enough clinical evidence to show this variant causes more severe illness. Knowing what symptoms to look for, taking sensible precautions, knowing about vaccination and being aware of genomic monitoring is important. Try not to cause unnecessary fear and instead focus on reliable medical information. If you start to experience symptoms get tested early and contact healthcare professionals. A balance of scientific research, awareness and sensible precautions will be key in managing the evolving nature of the virus.

